Solvay Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Solvay wird ein jährliches Gewinn- und Umsatzwachstum von 44.3% bzw. 0.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 41.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 37.3% betragen.
Wichtige Informationen
44.3%
Wachstumsrate der Gewinne
41.1%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 20.0% |
Wachstumsrate der Einnahmen | 0.2% |
Zukünftige Eigenkapitalrendite | 37.3% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 11 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Oct 17Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Sep 18Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
Aug 28Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Aug 08Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Jul 14Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Jun 14Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
May 29Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Apr 24Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Mar 10Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Nov 20Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Nov 06The Return Trends At Solvay (EBR:SOLB) Look Promising
Nov 02Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Oct 19Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
Aug 16Returns At Solvay (EBR:SOLB) Are On The Way Up
Aug 02Is Solvay (EBR:SOLB) A Risky Investment?
Jul 19An Intrinsic Calculation For Solvay SA (EBR:SOLB) Suggests It's 26% Undervalued
Jul 06Solvay's (EBR:SOLB) Dividend Will Be Increased To €1.76
May 11Is Solvay SA (EBR:SOLB) Potentially Undervalued?
May 09Solvay's (EBR:SOLB) Returns On Capital Are Heading Higher
Apr 25Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Apr 09Is There An Opportunity With Solvay SA's (EBR:SOLB) 21% Undervaluation?
Mar 27Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.76
Feb 27Solvay (EBR:SOLB) Has Announced That It Will Be Increasing Its Dividend To €1.08
Jan 09The Return Trends At Solvay (EBR:SOLB) Look Promising
Jan 05Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 20Solvay (EBR:SOLB) Seems To Use Debt Quite Sensibly
Dec 18At €94.20, Is Solvay SA (EBR:SOLB) Worth Looking At Closely?
Dec 02Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 17Solvay SA (EBR:SOLB) Shares Could Be 34% Below Their Intrinsic Value Estimate
Sep 13New Forecasts: Here's What Analysts Think The Future Holds For Solvay SA (EBR:SOLB)
Aug 07Is Now An Opportune Moment To Examine Solvay SA (EBR:SOLB)?
Jul 28We Think Solvay (EBR:SOLB) Can Stay On Top Of Its Debt
Jul 10Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 4,970 | 455 | 376 | 824 | 9 |
12/31/2025 | 4,810 | 395 | 329 | 762 | 11 |
12/31/2024 | 4,677 | 281 | 298 | 706 | 10 |
9/30/2024 | 5,217 | -64 | 196 | 618 | N/A |
6/30/2024 | 5,337 | 18 | 404 | 1,102 | N/A |
3/31/2024 | 5,570 | 127 | 804 | 1,731 | N/A |
12/31/2023 | 6,024 | -37 | 847 | 1,911 | N/A |
9/30/2023 | 497 | -384 | 1,162 | 2,372 | N/A |
6/30/2023 | 3,542 | -34 | 1,178 | 2,252 | N/A |
3/31/2023 | 6,038 | 495 | 977 | 1,945 | N/A |
12/31/2022 | 7,979 | 889 | 1,097 | 2,006 | N/A |
9/30/2022 | 15,442 | 1,859 | 998 | 1,775 | N/A |
6/30/2022 | 13,895 | 1,659 | 1,001 | 1,723 | N/A |
3/31/2022 | 12,523 | 1,176 | 897 | 1,578 | N/A |
12/31/2021 | 11,434 | 943 | 863 | 1,499 | N/A |
9/30/2021 | 10,575 | 648 | 927 | 1,440 | N/A |
6/30/2021 | 9,982 | 608 | 1,028 | 1,482 | N/A |
3/31/2021 | 9,631 | -1,168 | 1,158 | 1,603 | N/A |
12/31/2020 | 9,714 | -1,125 | 707 | 1,242 | N/A |
9/30/2020 | 10,006 | -1,216 | 771 | 1,408 | N/A |
6/30/2020 | 10,514 | -1,872 | 726 | 1,496 | N/A |
3/31/2020 | 11,055 | -134 | 742 | 1,585 | N/A |
12/31/2019 | 11,227 | -118 | 958 | 1,815 | N/A |
9/30/2019 | 11,347 | 111 | 1,223 | 2,081 | N/A |
6/30/2019 | 11,409 | 764 | 1,039 | 1,863 | N/A |
3/31/2019 | 11,349 | 767 | 741 | 1,572 | N/A |
12/31/2018 | 11,299 | 676 | 887 | 1,720 | N/A |
9/30/2018 | 11,187 | 775 | 737 | 1,582 | N/A |
6/30/2018 | 10,987 | 748 | N/A | 1,623 | N/A |
3/31/2018 | 10,953 | 730 | N/A | 1,649 | N/A |
12/31/2017 | 10,984 | 820 | N/A | 1,590 | N/A |
9/30/2017 | 10,851 | 771 | N/A | 1,602 | N/A |
6/30/2017 | 10,694 | 765 | N/A | 1,718 | N/A |
3/31/2017 | 10,057 | 717 | N/A | 1,800 | N/A |
12/31/2016 | 10,044 | 539 | N/A | 1,788 | N/A |
9/30/2016 | 9,168 | 317 | N/A | 1,694 | N/A |
6/30/2016 | 9,512 | 248 | N/A | 1,572 | N/A |
3/31/2016 | 10,146 | 220 | N/A | 1,626 | N/A |
12/31/2015 | 10,083 | 355 | N/A | 1,289 | N/A |
9/30/2015 | 11,068 | 325 | N/A | 1,591 | N/A |
6/30/2015 | 10,929 | 311 | N/A | 1,554 | N/A |
3/31/2015 | 10,793 | 376 | N/A | 1,436 | N/A |
12/31/2014 | 10,629 | 326 | N/A | 1,621 | N/A |
9/30/2014 | 10,425 | 317 | N/A | 1,275 | N/A |
6/30/2014 | 10,222 | 298 | N/A | 1,332 | N/A |
3/31/2014 | 10,086 | 182 | N/A | 1,251 | N/A |
12/31/2013 | 10,150 | 164 | N/A | 1,299 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SOLB wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1.4%).
Ertrag vs. Markt: SOLB wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: SOLB wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: SOLBDie Einnahmen des Unternehmens (0.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Belgian (4.7% pro Jahr).
Hohe Wachstumseinnahmen: SOLBDie Einnahmen des Unternehmens (0.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SOLBDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (37.3%)